The aim of our study was to explore the downstream effects of heme oxygenase‐1 (HO‐1), the rate‐limiting enzyme in the heme catabolism pathway, on the immune suppressive functions of human tumor‐associated BMDMs, found upregulated in our previous study.11 Here, HMOX1 is linked to neoplasm.